BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22566157)

  • 21. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.
    Domingues R; Montalvão P; Magalhães M; Santos R; Duarte L; Bugalho MJ
    J Endocrinol Invest; 2012 Dec; 35(11):975-80. PubMed ID: 22293219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
    Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
    Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.
    Ricketts CJ; Forman JR; Rattenberry E; Bradshaw N; Lalloo F; Izatt L; Cole TR; Armstrong R; Kumar VK; Morrison PJ; Atkinson AB; Douglas F; Ball SG; Cook J; Srirangalingam U; Killick P; Kirby G; Aylwin S; Woodward ER; Evans DG; Hodgson SV; Murday V; Chew SL; Connell JM; Blundell TL; Macdonald F; Maher ER
    Hum Mutat; 2010 Jan; 31(1):41-51. PubMed ID: 19802898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas.
    Schiavi F; Savvoukidis T; Trabalzini F; Grego F; Piazza M; Amistà P; Demattè S; Del Piano A; Cecchini ME; Erlic Z; De Lazzari P; Mantero F; Opocher G
    Ann N Y Acad Sci; 2006 Aug; 1073():190-7. PubMed ID: 17102086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phenotype of
    Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
    Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical paragangliomas: is SDH genetic analysis systematically required?
    Fakhry N; Niccoli-Sire P; Barlier-Seti A; Giorgi R; Giovanni A; Zanaret M
    Eur Arch Otorhinolaryngol; 2008 May; 265(5):557-63. PubMed ID: 17987308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck.
    Ding Y; Feng Y; Wells M; Huang Z; Chen X
    Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
    Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
    Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
    Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
    Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paragangliomas and paraganglioma syndromes].
    Boedeker CC
    Laryngorhinootologie; 2011 Mar; 90 Suppl 1():S56-82. PubMed ID: 21523634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL.
    Bourdeau I; Grunenwald S; Burnichon N; Khalifa E; Dumas N; Binet MC; Nolet S; Gimenez-Roqueplo AP
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4710-4718. PubMed ID: 27700540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma.
    Dannenberg H; Dinjens WN; Abbou M; Van Urk H; Pauw BK; Mouwen D; Mooi WJ; de Krijger RR
    Clin Cancer Res; 2002 Jul; 8(7):2061-6. PubMed ID: 12114404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.
    Timmers HJ; Pacak K; Bertherat J; Lenders JW; Duet M; Eisenhofer G; Stratakis CA; Niccoli-Sire P; Tran BH; Burnichon N; Gimenez-Roqueplo AP
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):561-6. PubMed ID: 17973943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.